Response Kinetics and Clinical Benefits of Nonintensive AML Therapies in the Absence of Morphologic Response

Stein, EM; DiNardo, CD; Pollyea, DA; Schuh, AC

Stein, EM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10065 USA.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020; 20 (2): E66

Abstract

The ultimate goal of treatment for acute myeloid leukemia (AML) is to improve survival, and the best means of doing so is through the induction of mor......

Full Text Link